scienceSaturday, July 4, 2026
Space-based pharma manufacturing is leaving the lab and entering the market, while on Earth the debate over how to cope with extreme heat gets a pointed critique. A new approach to reversing aging is also drawing serious attention.
The biggest science story today is a concrete step toward making drugs in space a real business.
Varda Space Industries is commercializing drug production in microgravity, partnering with United Therapeutics to test novel molecules. This moves orbital pharma from concept to business.
Two pieces examine how we respond to environmental stress, one from a public health angle, one from a personal one.
A Vox piece argues America's over-reliance on air conditioning is a fatal flaw in heat wave response, and that passive cooling techniques used elsewhere should be adopted.
A psychiatrist reflects on AI interactions as a mirror for human consciousness, arguing the real significance is what AI reveals about us, not the machines themselves.
Long-term challenges, reversing aging and cleaning the oceans, each get a fresh look.
Cellular reprogramming to reverse aging is gaining buzz and funding, with promising mouse studies pushing it beyond targeting individual hallmarks of aging.
Eos reports that 11 million tons of microplastics enter the ocean annually, and researchers are using new techniques to track their movement to inform policy.
sports roundup
health roundup
finance roundup
art roundup
education roundup
music roundup
